153 related articles for article (PubMed ID: 34181829)
1. [Virilization and metabolic disease in postmenopausal women related to ovarian hyperplasia and hypertecosis].
Larrea AL; González VR; Knoblovits P; Gil SJ
Rev Fac Cien Med Univ Nac Cordoba; 2021 Jun; 78(2):193-196. PubMed ID: 34181829
[TBL] [Abstract][Full Text] [Related]
2. Management of postmenopausal virilization.
Alpañés M; González-Casbas JM; Sánchez J; Pián H; Escobar-Morreale HF
J Clin Endocrinol Metab; 2012 Aug; 97(8):2584-8. PubMed ID: 22669303
[TBL] [Abstract][Full Text] [Related]
3. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Hirschberg AL
J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
5. Ovarian hilus-cell hyperplasia and high serum testosterone in a patient with postmenopausal virilization.
Delibasi T; Erdogan MF; Serinsöz E; Kaygusuz G; Erdogan G; Sertçelik A
Endocr Pract; 2007 Sep; 13(5):472-5. PubMed ID: 17872348
[TBL] [Abstract][Full Text] [Related]
6. An unusual circulating steroid profile in a virilized postmenopausal woman.
Benavent Correro P; Sáenz Valls M; García Cano A; Jiménez Mendiguchia L; Moreno Moreno E; Luque-Ramírez M
Diagnosis (Berl); 2018 Jun; 5(2):83-87. PubMed ID: 29752879
[TBL] [Abstract][Full Text] [Related]
7. Leydig cell hyperplasia as a cause of virilization in a postmenopausal woman: A case report.
Vatopoulou A; Gkrozou F; Birbas E; Kanavos T; Skentou C; Miliaras D
Case Rep Womens Health; 2023 Sep; 39():e00537. PubMed ID: 37692362
[TBL] [Abstract][Full Text] [Related]
8. Approach to the Virilizing Girl at Puberty.
Santi M; Graf S; Zeino M; Cools M; Van De Vijver K; Trippel M; Aliu N; Flück CE
J Clin Endocrinol Metab; 2021 Apr; 106(5):1530-1539. PubMed ID: 33367768
[TBL] [Abstract][Full Text] [Related]
9. A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.
Zhou WB; Chen N; Li CJ
BMC Endocr Disord; 2019 Jan; 19(1):14. PubMed ID: 30674304
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal virilization due to ovarian hyperthecosis.
Agorastos T; Argyriadis N; Fraggidis G; Vakiani A; Zournatzi V; Bontis J
Arch Gynecol Obstet; 1995; 256(4):209-11. PubMed ID: 7503594
[TBL] [Abstract][Full Text] [Related]
11. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
Taylor HC; Pillay I; Setrakian S
Mayo Clin Proc; 2000 Mar; 75(3):288-92. PubMed ID: 10725957
[TBL] [Abstract][Full Text] [Related]
12. Virilization in a postmenopausal woman as a result of hilus cell hyperplasia associated with a simple ovarian cyst.
Hayes FJ; Sheahan K; Rajendiran S; McKenna TJ
Am J Obstet Gynecol; 1997 Mar; 176(3):719-20. PubMed ID: 9077639
[TBL] [Abstract][Full Text] [Related]
13. A case of postmenopausal androgen excess.
Lambrinoudaki I; Dafnios N; Kondi-Pafiti A; Triantafyllou N; Karopoulou E; Papageorgiou A; Augoulea A; Armeni E; Creatsa M; Vlahos N
Gynecol Endocrinol; 2015 Oct; 31(10):760-4. PubMed ID: 26287476
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis.
Manieri C; Di Bisceglie C; Fornengo R; Grosso T; Zumpano E; Calvo F; Berardengo E; Volante M; Papotti M
J Endocrinol Invest; 1998 Feb; 21(2):128-32. PubMed ID: 9585388
[TBL] [Abstract][Full Text] [Related]
15. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
Souto SB; Baptista PV; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
[TBL] [Abstract][Full Text] [Related]
17. Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature.
Czyzyk A; Latacz J; Filipowicz D; Podfigurna A; Moszynski R; Jasinski P; Sajdak S; Gaca M; Genazzani AR; Meczekalski B
Gynecol Endocrinol; 2017 Nov; 33(11):836-839. PubMed ID: 28604129
[TBL] [Abstract][Full Text] [Related]
18. Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.
Sanz OA; Martinez PR; Guarch RT; Goñi MJ; Alcazar JL
Maturitas; 2007 Jun; 57(2):214-6. PubMed ID: 17289310
[TBL] [Abstract][Full Text] [Related]
19. MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).
Gheorghisan-Galateanu AA; Terzea D; Valea A; Carsote M
Acta Endocrinol (Buchar); 2017; 13(3):356-363. PubMed ID: 31149200
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hyperandrogenism: the under-recognized value of inhibins.
Shearer JL; Salmons N; Murphy DJ; Gama R
Ann Clin Biochem; 2017 Jan; 54(1):174-177. PubMed ID: 27278937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
